Drugs / Liquid Peanut Extract
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01373242 | Jun 2011 → Apr 2018 | food allergy | University of North Carolina, Chapel Hill | Completed | No outcome recorded |
| Phase 21 trial · 1 met primary | ||||||
| Phase 2 | NCT02304991 | Jan 2015 → Dec 2020 | food allergy | University of North Carolina, Chapel Hill | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liquid peanut extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01373242 ↗ |
| Modality | Protein / enzyme biologic | “5000mcg/ml peanut protein” NCT02304991 ↗ |
| Route | Other | “Liquid peanut extract will be administered under the tongue” NCT01373242 ↗ |